Clinical trial design for immunomodulatory biologics.
Division of Clinical Trial Design and Analysis, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20852-1448, USA.
D M
DM
Essayan
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D012107:Research Design
D000276:Adjuvants, Immunologic